Recently, engineered exosome producer cells implanted in a mouse model of Parkinson disease successfully prevented 6-OHDA-induced cell death by efficient production and delivery of exosomes containing catalase mRNA into the brain, opening the door for new ways to achieve therapeutic effects. This evidence concerns the gene CAT and Parkinson disease.